Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Ford

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of painDavid S Carter, Muzaffar Alam, Haiying Cai, et al.
The Journal of Urology|October 20, 2007
Effects of the selective prostacyclin receptor antagonist RO3244019 on the micturition reflex in ratsJoseph S Cefalu, Quan Ming Zhu, Anne-Christin Eggers, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Identification of a 5-HT4 receptor antagonist clinical candidate through side-chain modificationRobin D Clark, Alam Jahangir, Muzaffar Alam, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of painAlam Jahangir, Muzaffar Alam, David S Carter, et al.
Plos One|January 22, 2015
Isoproterenol acts as a biased agonist of the alpha-1A-adrenoceptor that selectively activates the MAPK/ERK pathwayAlicja J Copik, Aleksander Baldys, Khanh Nguyen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 18, 2004
Uropathic observations in mice expressing a constitutively active point mutation in the 5-HT3A receptor subunitAnindya Bhattacharya, Hong Dang, Quan-Ming Zhu, et al.
British Journal of Pharmacology|July 2, 2010
AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonistJoel R Gever, Rothschild Soto, Robert A Henningsen, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2010
Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonistChristine E Brotherton-Pleiss, Michael P Dillon, Anthony P D W Ford, et al.
Brain : a Journal of Neurology|August 31, 2010
Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in ratsTimothy K Y Kaan, Ping K Yip, Sital Patel, et al.
The Journal of Physiology|June 18, 2005
P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATPDebra A Cockayne, Philip M Dunn, Yu Zhong, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of painDavid S Carter, Muzaffar Alam, Haiying Cai, et al.
The Journal of Urology|October 20, 2007
Effects of the selective prostacyclin receptor antagonist RO3244019 on the micturition reflex in ratsJoseph S Cefalu, Quan Ming Zhu, Anne-Christin Eggers, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Identification of a 5-HT4 receptor antagonist clinical candidate through side-chain modificationRobin D Clark, Alam Jahangir, Muzaffar Alam, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of painAlam Jahangir, Muzaffar Alam, David S Carter, et al.
Plos One|January 22, 2015
Isoproterenol acts as a biased agonist of the alpha-1A-adrenoceptor that selectively activates the MAPK/ERK pathwayAlicja J Copik, Aleksander Baldys, Khanh Nguyen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 18, 2004
Uropathic observations in mice expressing a constitutively active point mutation in the 5-HT3A receptor subunitAnindya Bhattacharya, Hong Dang, Quan-Ming Zhu, et al.
British Journal of Pharmacology|July 2, 2010
AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonistJoel R Gever, Rothschild Soto, Robert A Henningsen, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2010
Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonistChristine E Brotherton-Pleiss, Michael P Dillon, Anthony P D W Ford, et al.
Brain : a Journal of Neurology|August 31, 2010
Systemic blockade of P2X3 and P2X2/3 receptors attenuates bone cancer pain behaviour in ratsTimothy K Y Kaan, Ping K Yip, Sital Patel, et al.
The Journal of Physiology|June 18, 2005
P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATPDebra A Cockayne, Philip M Dunn, Yu Zhong, et al.
Pageof 5